{"schema_version":"secwatch.filing_event.v1","accession":"0000947871-23-000768","form_type":"8-K","ticker":"LIDR","cik":"0001818644","company_name":"AEye, Inc.","filed_at":"2023-07-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.414047+00:00","generated_at":"2026-06-13T05:44:41.151207+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AEye receives second 180-day Nasdaq compliance extension until Jan 16, 2024 for bid price rule","bullets":["Nasdaq granted AEye second 180-day period until Jan 16, 2024 to regain $1.00 minimum bid price.","Company failed to regain compliance by first deadline July 19, 2023.","No immediate effect on LIDR listing; continues trading on Nasdaq under symbol LIDR.","If not compliant by Jan 16, 2024, Nasdaq may delist; company may appeal.","AEye may consider reverse stock split to cure the bid price deficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-23-000768","json":"https://secwatch.observer/filing/0000947871-23-000768.json","markdown":"https://secwatch.observer/filing/0000947871-23-000768.md","text":"https://secwatch.observer/filing/0000947871-23-000768.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818644/000094787123000768/0000947871-23-000768-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818644/000094787123000768/ss2304128_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T05:44:41.151207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"619603c5bdf8f5fab0590f52bba12647afcbf370","claim":"AEye, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"July 20, 2023, the Company was notified by Nasdaq that the Company had been granted a second 180-calendar day period, or until January 16, 2024 (the “Second Compliance Date”), to regain compliance and cure the deficiency, provided that the Company continues to meet the continued listing requirements of Nasdaq, other than the Bid Price Rule. This action has no immediate effect on the Company’s Nasdaq listing and its common stock will continue to be listed under the symbol “LIDR.” If the Company does not regain compliance with the Bid Price Rule prior to the Second Compliance Date, Nasdaq is exp","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818644/000094787123000768/0000947871-23-000768-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"extension granted"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}